)
Aardvark Therapeutics (AARD) investor relations material
Aardvark Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by CEO, who also served as Chairman; CFO acted as Secretary and an independent auditor was introduced.
Agenda included election of two Class I directors, ratification of the independent auditor, and approval of stock option repricing.
Rules of conduct and procedures were outlined, with validated stockholders allowed to ask questions on agenda items.
Board and executive committee updates
Two current directors, Jeffrey Chi and Victor Tong Jr., were nominated for re-election as Class I directors to serve until the 2029 Annual Meeting.
No advance notice of other director nominations was received.
Shareholder proposals
No additional shareholder proposals were received for this annual meeting.
- Q2 2026 net loss was $14.4M; ARD-101 program on FDA hold, future plans under review.AARD
Q2 2026 - Shareholders will vote on director elections, auditor ratification, and stock option repricing.AARD
Proxy filing - Phase III oral therapy for Prader-Willi shows strong efficacy, safety, and pipeline expansion.AARD
Morgan Stanley 23rd Annual Global Healthcare Conference - Phase 3 Prader-Willi data expected Q3 2026; ARD-201 obesity study results due end of next year.AARD
Piper Sandler 37th Annual Healthcare Conference - Annual meeting to vote on directors, auditor, and stock option repricing, with strong governance focus.AARD
Proxy filing - Clinical programs paused for safety review; net loss rises, cash supports operations into mid-2027.AARD
Q1 2026 - Biopharma seeks $400M shelf, $150M ATM for R&D; lead trials paused for safety review.AARD
Registration filing - Clinical trial pauses and strong cash reserves define the period, with guidance due in Q2 2026.AARD
Q4 2025 - New gut-brain drugs show promise for obesity and Prader-Willi, with pivotal trials underway.AARD
Cantor Global Healthcare Conference 2025
Next Aardvark Therapeutics earnings date
Next Aardvark Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage